Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
- The primary objectives of this placebo-controlled clinical trial are to evaluate the
analgesic efficacy and safety of bicifadine 200 mg BID compared with placebo in patients
with moderate to severe chronic low back pain.
- The secondary objectives are to evaluate the effect of bicifadine on function and
general quality of life, to evaluate safety following discontinuation of bicifadine
treatment and to investigate the population pharmacokinetics of bicifadine.